OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 22, 2017
The company expanded its UK storage facility to meet increasing demand from its growing customer base.
May 18, 2017
The company installed the FlexFactory to support its biosimilar production.
The compendium provides a resource to identify and locate targeted suitable patient-derived xenografts based on specific histology and molecular properties.
May 17, 2017
The new storage and distribution facility provides PCI with additional space, complementing its existing footprint currently used for specialist clinical-trial logistics as well as packaging, labeling, and qualified person activities for investigational medicinal products.
May 15, 2017
Catalent has signed an agreement with Therachon to support preclinical and clinical development of TA-46, a novel protein being developed to treat achondroplasia.
Catalent has been working together with Lexicon to develop the drug formulation of Xermelo, which has now been approved by FDA for the treatment of carcinoid syndrome diarrhea.
The existing, obsolete highpurity water generation system and water-forinjection generation system were replaced with new, reliable technologies.
May 11, 2017
The company invested approximately $26 million to update its sterile pharmaceutical and development service suites.
May 10, 2017
The company has formed a Pediatric Center of Excellence in support of the development and manufacture of dosage forms for pediatric indications.
May 02, 2017
New incubators, instrumentation, and staff will increase cell bioassay capabilities for EAG Laboratories.